SCHEMBL8329882

SCHEMBL8329882

C=CCC(C(N)=O)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
CYP2C19 P33261 1/20 0.42
TNF P01375 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
FFAR2 O15552 1/20 0.37
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
CDC7 O00311 1/20 0.35
PLK4 O00444 1/20 0.35
CHEK1 O14757 1/20 0.35
DCLK1 O15075 1/20 0.35
MAPK13 O15264 1/20 0.35
PDPK1 O15530 1/20 0.35
DAPK3 O43293 1/20 0.35
DYRK3 O43781 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8329884 1.00 SLC6A2 (0.43) SLC6A2SLC6A4SLC6A3CYP2C19TNF
SCHEMBL623726 0.86 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3CYP2C19TNF
SCHEMBL5879212 0.86 CYP2C19 (0.60) SLC6A2SLC6A4SLC6A3CYP2C19ALDH1A1
SCHEMBL624052 0.86 CYP2C19 (0.60) SLC6A2SLC6A4SLC6A3CYP2C19ALDH1A1
SCHEMBL5879216 0.86 CYP2C19 (0.60) SLC6A2SLC6A4SLC6A3CYP2C19ALDH1A1
SCHEMBL5879182 0.86 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3CYP2C19TNF
SCHEMBL5879184 0.86 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3CYP2C19TNF
SCHEMBL8067450 0.84 ALDH1A1 (0.43) SLC6A2SLC6A4SLC6A3CYP2C19ALDH1A1
SCHEMBL8067451 0.84 ALDH1A1 (0.43) SLC6A2SLC6A4SLC6A3CYP2C19ALDH1A1
SCHEMBL19803300 0.82 FFAR2 (0.51) CYP2C19LMNAFFAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5962462-A COMPOUNDS WHICH INHIBIT THE ENTRY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTO TARGET CELLS; DELAYING THE ONSET OF ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS). MERCK & CO., INC. (US) 1999-10-05 US disclosed
WO-1998025605-A1 SPIRO-SUBSTITUTED AZACYCLES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 1998-06-18 WO disclosed